We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A 36-year-old man with seronegative rheumatoid arthritis ...

Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis, particularly older women, who are overweight demonstrate less joint space ...

The need for joint replacement in rheumatoid arthritis patients has waned since the advent of more effective treatments in the mid-2000s, but as a group, those who undergo this surgery remain at high ...

Schematic illustration of comprehensive and combination RA therapy by Ce-MSCNV nanoparticles. Ce-MSCNVs scavenge the over-produced ROS in an RA knee joint, induce M1 to M2 macrophage polarization for ...

Rheumatoid arthritis (RA) inflammation attacks the tissue lining your joints and causes swelling and pain. Inflamed joint tissue breaks down and wears away. Without medications to treat and control RA ...

Conventional disease-modifying antirheumatic drugs (DMARDs) may usually be continued in patients with inflammatory arthritis or systemic lupus erythematosus (SLE) undergoing total knee or hip ...

Medically reviewed by Stella Bard, MD Osteoarthritis develops from joint tissue wearing down over time, while rheumatoid ...

Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...

Although it is important to be able to identify patients who will experience a severe course of rheumatoid arthritis (RA), because these patients would benefit from early, aggressive treatment, ...

Researchers have developed a nanoparticle-based platform for treating rheumatoid arthritis (RA) that comprises ceria nanoparticles (Ce NPs) immobilized onto mesenchymal stem cell-derived nanovesicles ...